All Stories

  1. Magnetic Resonance Imaging-Based Predictive Models for Clinically Significant Prostate Cancer: A Systematic Review
  2. Multiparametric MRI for Staging of Prostate Cancer: A Multicentric Analysis of Predictive Factors to Improve Identification of Extracapsular Extension before Radical Prostatectomy
  3. Proclarix, A New Biomarker for the Diagnosis of Clinically Significant Prostate Cancer: A Systematic Review
  4. Multiparametric Magnetic Resonance Imaging Grades the Aggressiveness of Prostate Cancer
  5. Application of One-Step Nucleic Acid Amplification (OSNA) in different cancer entities and usefulness in prostate cancer: a systematic review
  6. Continence definition and prognostic factors for early urinary continence recovery in posterior rhabdosphincter reconstruction after robot-assisted radical prostatectomy. Post-hoc analysis of a randomised controlled trial
  7. The Barcelona Predictive Model of Clinically Significant Prostate Cancer
  8. Improving the Early Detection of Clinically Significant Prostate Cancer in Men in the Challenging Prostate Imaging-Reporting and Data System 3 Category
  9. Who with suspected prostate cancer can benefit from Proclarix after multiparametric magnetic resonance imaging?
  10. The Efficacy of Proclarix to Select Appropriate Candidates for Magnetic Resonance Imaging and Derived Prostate Biopsies in Men with Suspected Prostate Cancer
  11. Re: Aina Salazar, Lucas Regis, Jacques Planas, et al. A Randomised Controlled Trial to Assess the Benefit of Posterior Rhabdosphincter Reconstruction in Early Urinary Continence Recovery after Robot-assisted Radical Prostatectomy. Eur Urol Oncol. In pr...
  12. The current recommendation for the management of isolated high‐grade prostatic intraepithelial neoplasia
  13. The current value of histological findings in negative prostate biopsies to predict the future risk of clinically significant prostate cancer
  14. The position of urethrovesical anastomosis after robotic radical prostatectomy assessed by MRI predicts early functional recovery: A cohort analyses from a randomized clinical trial
  15. A Randomised Controlled Trial to Assess the Benefit of Posterior Rhabdosphincter Reconstruction in Early Urinary Continence Recovery after Robot-assisted Radical Prostatectomy
  16. Prediction of clinically significant prostate cancer after negative prostate biopsy: The current value of microscopic findings
  17. Serum Luteinizing Hormone Testing Can Identify Optimal Medical Castration
  18. Prostatic-specific antigen density behavior according to multiparametric magnetic resonance imaging result
  19. Variaciones de la prostatectomía radical para una recuperación de la continencia urinaria precoz: una revisión sistemática
  20. Who Benefits from Multiparametric Magnetic Resonance Imaging After Suspicion of Prostate Cancer?
  21. Las biopsias de próstata dirigidas ¿están listas para reemplazar las biopsias de próstata sistemáticas?
  22. How to implement magnetic resonance imaging before prostate biopsy in clinical practice: nomograms for saving biopsies
  23. Análisis del escenario microscópico de una biopsia prostática negativa como predictor del riesgo de cáncer de próstata. Una revisión sistemática
  24. Valor de la proteína STAT3 como factor pronóstico en el carcinoma renal de célula clara. Revisión sistemática
  25. La resonancia magnética preoperatoria predice la recuperación temprana de la continencia urinaria tras la prostatectomía radical robótica
  26. The role of negative magnetic resonance imaging: can we safely avoid biopsy in P.I.-R.A.D.S. 2 as in P.I.-R.A.D.S. 1?
  27. Revisión sistemática de los métodos predictores de la funcionalidad del trasplante renal
  28. Serum Testosterone Levels in Prostate Cancer Patients Undergoing Luteinizing Hormone-Releasing Hormone Agonist Therapy
  29. Accuracy of serum luteinizing hormone and serum testosterone measurements to assess the efficacy of medical castration in prostate cancer patients
  30. Revisión sistemática de los factores pronósticos del carcinoma renal
  31. Métodos para cuantificar la testosterona sérica en pacientes con cáncer de próstata sometidos a castración: una revisión sistemática
  32. Free Testosterone During Androgen Deprivation Therapy Predicts Castration-Resistant Progression Better Than Total Testosterone
  33. Cambios hormonales después del tratamiento de cáncer de próstata localizado. Comparación entre radioterapia de haz externo y prostatectomía radical
  34. Hormonal response recovery after long-term androgen deprivation therapy in patients with prostate cancer
  35. Testosterone assays? Maybe your patients under ADT aren't well castrated ...
  36. Determinación de la testosterona sérica durante la supresión androgénica en pacientes con cáncer de próstata: una revisión sistemática
  37. Comportamiento de la testosterona total y libre en suero como predictores del riesgo de cáncer de próstata y de su agresividad
  38. Simultaneous Treatment with Statins and Aspirin Reduces the Risk of Prostate Cancer Detection and Tumorigenic Properties in Prostate Cancer Cell Lines
  39. Bone mass behavior after 1 year of different treatment strategies in prostate cancer patients subjected to androgen deprivation therapy
  40. Bladder Cancer in an Inguinoscrotal Vesical Hernia